Abstract
Poly(ethylene glycol) (PEG) derivatives are the first choice of the water soluble, biocompatible polymers on hand for conjugation to proteins and polypeptides. This chapter deals with the PEG reagents that are available for the preparation of bioconjugates. The opportunities of different reactive groups on PEG are described and their different activities against the functional moieties of the amino acids are illustrated. Some attention is also given to the modification of the PEG backbone to increase its loading capacity and to eventually modify the stability of the conjugating bonds.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Properties and Use of Polyethylene Glycol (1977), Hoechst Polyglycol s Katalog
Zalipsky S (1995) Functionalized Poly(ethylene glycol) for Preparation of Biologically Relevant Conjugates. Bioconjugate Chem., 6:150–165
Harris JM (1985) Laboratory Synthesis of Polyethylene Glycol Derivatives. JMS-Rev. Macromol. Chem. Phys., C25:325–373
Lundblad RL (2005) Chemical Reagents for Protein Modification 3rd Edit. CRC Press
Pedder S (2001) PEGASYS®: A true once-a-week antiviral. Annual Meeting, American Association of the Study of Liver Diseases (AASLD), Dallas, TX
Sartore L, Caliceti P, Schiavon O, Monfardini C, Veronese FM (1991) Accurate evaluation method of the polymer content in monomethoxy poly(ethylene glycol)modified proteins based on amino acid analysis. Appl. Biochem. Biotechnol., 31:213–222.
Zalipsky S, Lee C (1992) Use of functionalized poly(ethylene glycol) s for modification of polypeptides. In: JM Harris, S Zalipsky (Eds.), Polyethylene Glycol Chemistry, Biotechnical and Biomedical Applications, Plenum, New York, pp. 347–370
Francis GE, Fisher D, Delgado C, Malik F, Gardiner A, Neale D (1998) PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimization of coupling techniques. Int. J. Hematol., 68:1–18
Harris JM, Herati RM (1993) Preparation and use of poly-ethylene glycol propionaldehyde. US Patent 5,252,714
Kinstler OB, Brems DN, Lauren SL (1996) Characterization and stability of N-terminally PEGylated rhG-CSF. Pharm Res., 13:996–1002
Kinstler OB, Gabriel NE, Farrar CE, DePrince RB (1999) N-terminally chemically modified protein compositions and methods, US Patent 5,985,265
Edwards CK (1993) PEGylated recombinant human soluble tumor necrosis factor receptor type I (rHu-sTNF-RI): A novel high-affinity TNF receptor designed for chronic inflammatory diseases. Ann. Rheum. Dis., 58:173–181
Zalipsky S, Seltzer R, Menon-Rudolph S (1992) Evaluation of a new reagent for covalent attachment of polyethylene glicol to proteins. Biotechnol. Appl. Biochem., 15:100–114
Miron T, Wilchek M (1993) A simplified method for the preparation of succinimidyl carbonate polyethylene glycol for coupling to proteins. Bioconjug. Chem., 4:568–569
Dolence EK, Hu C, Tsang R, Sanders CG, Osaki S (1997) Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces. US Patent 5,650,234
Veronese FM, Largajolli R, Boccu E, Benassi CA, Schiavon O (1985) Activation of monomethoxy poly(ethylene glycol) by phenylchloroformate and modification of ribonuclease and superoxide dismutase. Appl. Biochem. Biotechnol., 11:141–152
Beauchamp CO, Gonias SL, Menapace DP, Pizzo SV (1983) A new procedure for the synthesis of polyethylene glycolglycol protein adducts, effects on function, receptor recognition and clearance of superoxide dismutase, lactoferrin and a2-macro-globulin. tAnal. Biochem., 131:25–33
Carter MC, Meyerhoff ME (1985) Instability of succinyl ester linkages in 029-monosuccinyl cyclic AMP-protein conjugates at neutral pH. J. Immunol. Methods, 81:245–257
Abuchowski J, Kazo GM, Verhoest CR (1984) Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates. Cancer Biochem. Biophys., 7:175–186
Zalipsky S, Barany G (1986) Preparation of polyethylene glycol derivatives with two different functional groups at the termini. Polym. Preprints, 27:1–2
Zalipsky S, Barany G (1990) Facile synthesis of α-hydroxy-ω-carboxymethylpolyethylene oxide. J. Bioact. Compat. Polym., 5:227–231
Harris JM, Kozlowski A (1997) Polyethylene glycol and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications. US Patent 5,672,662
Sartore L, Caliceti P, Schiavon O, Veronese FM (1991) Enzyme modification by MPEG with amino acid or peptide as spacer arm. Appl. Biochem. Biotechnol., 27:55–63
Veronese FM, Saccà B, Polverino de Laureto P, Sergi M, Caliceti P, Schiavon O (2001) New PEGs for peptide and protein modification, suitable for identification of the PEGylation site. Bioconjugate Chem., 12:62–70
Goodson RJ, Katre NV (1990) Site-directed pegylation of recomproteins binant interleukin-2 at its glycosylation site. Biotechnology, 8:343–346
Kogan TP (1992) The synthesis of substituted methoxy-polymer (ethylene glycol) derivatives suit able for selective protein modification. Synth. Commun., 22:2417–2424
Morpurgo M, Veronese FM, Kachensky D, Harris JM (1976) Preparation and characterization of poly(ethylene glycol) vinyl sulfone. Bioconjug. Chem., 7:363–368
Woghiren C, Sharma B, Stein S (1993) Protected thiol-polycoupling ethylene glycol: a new acti vated polymer for reversibile protein modification. Bioconjug. Chem., 4:314–318
Gard FRN (1972) Carboxymethylation. Methods Enzymol., B25:424–449
Greenwald RB, Pendri A, Bolikal D (1995) Highly soluble taxol derivatives: 7-polyethylene glycol carbamates and carbonates. J. Org. Chem., 60:331–336
Pace G, Veronese FM, Bonora GM (1999) Synthesis and reactivity of high-molecular mass phosphorylated poly(ethylene glycol). Reactive & Functional Polimers, 41:141–148
De Frees S, Wang ZG, Xing R (2006) GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli. Giycobiology 16:833–843
Zalipski S, Menon-Rudolph S (1997) Hydrazide derivatives of poly(ethylene glycol) and their bioconjugates. Poly(ethylene glycol) chemistry and biological applications. ACS Symp Ser, 680:318–341
Yankeelov Jr AJA (1972) Modification of arginine by diketones. Methods Enzymol., B25:566–584
Maeda H, Kai Y, Ono K (1989) Polyethylene glycol derivatives, modified, peptides and production thereof. E.P. 0.340.741
Sato H (2002) Enzymatic procedure for site-specific PEGylation of proteins, Adv. Drug Deliv. Rev., 54:487–504
Fontana A, Spolaore B, Mero A, Veronese FM (2008) Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase, Adv. Drug Deliv. Rev. 60:13–28
Monfardini C, Schiavon O, Caliceti P, Morpurgo M, Harris JM, Veronese FM (1995) A Branched Monomethoxypoly(ethylene glycol) for Protein Modification, Bioconjugate Chem., 6:62–69
Schiavon O, Pasut G, Moro S, Orsolini P, Guiotto A, Veronese FM (2004) PEG-Ara C conjugation for controlled release. Eur. J. Med. Chem., 39(2):123–133
Pasut G, Scaramuzza S, Schiavon O, Mendichi R, Veronese FM (2005) PEG-epirubicin conjugates with high drug loading. J. of Bioactive and Compatible Polymers 20:213–230
Liu X-M, Thakur A, Wang D (2007) Efficient Synthesis of Linear Multifunctional Poly(ethylene glycol) by Copper(I)-Catalyzed Huisgen 1,3-Dipolar Cycloaddition. Biomacromolecules, 8:2653–2658
Ballico M, Drioli S, Bonora GM (2005) MultiPEG: high molecular weight multifunctional poly(ethylen glycol)s assembled by a dendrimer-like approach. EJOC, 2064–2067
Drioli S, Bonora GM, Ballico M (2008) Synthesis and characterization of new multifunctional high-molecular weight PEG derivatives (MultiPEG)s. The Open Organic Chemistry Journal 2:17–25
Harris JM, Chess RB (2003) Effect of PEGylation on Pharmaceuticals. Nature Reviews Drug Discovery 2:214–221
Roberts MJ, Bentley MD, Harris JM (2002) Chemistry for peptide and protein PEGylation. Adv. Drug Del. Rev. 54:459–476
Zhao X, Harris JM (1997) Novel degradable poly(ethylene glycol) esters for drug delivery. In: JM Harris, S Zalipsky (eds): Poly(ethylene glycol) chemistry and biological applications. American Chemical Society, Washington, DC, 458–472
Testa B, Mayer JM (eds): (2003) Hydrolysis in drug and prodrug metabolism: Chemistry, biochemistry, and enzymology. Verlag Helvetica Chimica Acta, Wiley-VCH, Switzerland
Zalipsky S, Qazen M, Walker II JA, Mullah N, Quinn YP, Huang SK (1999) New detachable poly(ethylene glycol) conjugates: Cysteine-cleavable lipopolymers regenerating natural phospholipids, diacyl phosphatidylethanolamine. Bioconjug. Chem. 10:703–707
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Birkhäuser Verlag/Switzerland
About this chapter
Cite this chapter
Bonora, G.M., Drioli, S. (2009). Reactive PEGs for protein conjugation. In: Veronese, F.M. (eds) PEGylated Protein Drugs: Basic Science and Clinical Applications. Milestones in Drug Therapy. Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8679-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-7643-8679-5_3
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-7643-8678-8
Online ISBN: 978-3-7643-8679-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)